Investigation of serum proteome alterations in human endometriosis

Journal of Proteomics

Volumn 114, Issue , 2015, Pages 182-196

  Dutta, Mainak ^a   Subramani, Elavarasan ^a   Taunk, Khushman ^b   Gajbhiye, Akshada ^b   Seal, Shubhendu ^c   Pendharkar, Namita ^b   Dhali, Snigdha ^b   Ray, Chaitali Datta ^d   Lodh, Indrani ^e   Chakravarty, Baidyanath ^e   Dasgupta, Swagata ^a   Rapole, Srikanth ^b   Chaudhury, Koel ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

^c Wipro GE Healthcare   (India)

^d INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^e Institute of Reproductive Medicine   (India)

Author keywords

2D DIGE; Endometriosis; Pathogenesis; Protein markers; Serum

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN M; BETA2 GLYCOPROTEIN 1; CLUSTERIN; COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C9; COMPLEMENT FACTOR H; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEIN; HAPTOGLOBIN; HEMOPEXIN; INTER ALPHA TRYPSIN INHIBITOR; PROTEOME; SERUM ALBUMIN; SERUM AMYLOID P; TRIACYLGLYCEROL; TRIPARTITE MOTIF PROTEIN 5; VERY LOW DENSITY LIPOPROTEIN; BIOLOGICAL MARKER; PLASMA PROTEIN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIOSIS; FEMALE; GENE ONTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; WESTERN BLOTTING; BLOOD; CASE CONTROL STUDY; MASS SPECTROMETRY; METABOLISM; PATHOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDOMETRIOSIS; FEMALE; HUMANS; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 84916895096     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.10.021     Document Type: Article

References (95)

1. Ferrero S., Gillott D.J., Remorgida V., Anserini P., Leung K.Y., Ragni N., et al. Proteomic analysis of peritoneal fluid in women with endometriosis. J Proteome Res 2007, 6:3402-3411.
2. Lee C.H., Huang Y.C., Huang S.F., Wu Y.K., Kuo K.T. Thoracic endometriosis: rare presentation as a solitary pulmonary nodule with eccentric cavitations. Thorax 2009, 64:919-920.
3. Attia L., Ben Temime R., Sidhom J., Sahli A., Makhlouf T., Chachia A., et al. A case of cutaneous endometriosis developed on an abdominal scar. Tunis Med 2010, 88:841-843.
4. Luisi S., Gabbanini M., Sollazzi S., Calonaci F., Razzi S., Petraglia F. Surgical scar endometriosis after Cesarean section: a case report. Gynecol Endocrinol 2006, 22:284-285.
5. Mistrangelo M., Gilbo N., Cassoni P., Micalef S., Faletti R., Miglietta C., et al. Surgical scar endometriosis. Surg Today 2014, 44:767-772.
6. Oei S.G., Peters A.A., Welvaart K., Bode P.J., Fleuren G.J. Aggressive endometriosis in bone. Lancet 1992, 339:1477-1478.
7. Ichida M., Gomi A., Hiranouchi N., Fujimoto K., Suzuki K., Yoshida M., et al. A case of cerebral endometriosis causing catamenial epilepsy. Neurology 1993, 43:2708-2709.
8. Sarma D., Iyengar P., Marotta T.R., terBrugge K.G., Gentili F., Halliday W. Cerebellar endometriosis. AJR Am J Roentgenol 2004, 182:1543-1546.
9. Jones G.L., Kennedy S.H., Jenkinson C. Health-related quality of life measurement in women with common benign gynecologic conditions: a systematic review. Am J Obstet Gynecol 2002, 187:501-511.
10. Hadfield R., Mardon H., Barlow D., Kennedy S. Delay in the diagnosis of endometriosis: a survey of women from the USA and the UK. Hum Reprod 1996, 11:878-880.
11. Tabibzadeh S., Becker J.L., Parsons A.K. Endometriosis is associated with alterations in the relative abundance of proteins and IL-10 in the peritoneal fluid. Front Biosci 2003, 8:a70-a78.
12. Fowler P.A., Tattum J., Bhattacharya S., Klonisch T., Hombach-Klonisch S., Gazvani R., et al. An investigation of the effects of endometriosis on the proteome of human eutopic endometrium: a heterogeneous tissue with a complex disease. Proteomics 2007, 7:130-142.
13. Ten Have S., Fraser I., Markham R., Lam A., Matsumoto I. Proteomic analysis of protein expression in the eutopic endometrium of women with endometriosis. Proteomics Clin Appl 2007, 1:1243-1251.
14. Rai P., Kota V., Deendayal M., Shivaji S. Differential proteome profiling of eutopic endometrium from women with endometriosis to understand etiology of endometriosis. J Proteome Res 2010, 9:4407-4419.
15. Zhang H., Niu Y., Feng J., Guo H., Ye X., Cui H. Use of proteomic analysis of endometriosis to identify different protein expression in patients with endometriosis versus normal controls. Fertil Steril 2006, 86:274-282.
16. Wang L., Zheng W., Yu J.K., Jiang W.Z., Mu L., Zhang S.Z. Artificial neural networks combined with surface-enhanced laser desorption/ionization mass spectra distinguish endometriosis from healthy population. Fertil Steril 2007, 88:1700-1702.
17. Jing J., Qiao Y., Suginami H., Taniguchi F., Shi H., Wang X. Two novel serum biomarkers for endometriosis screened by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and their change after laparoscopic removal of endometriosis. Fertil Steril 2009, 92:1221-1227.
18. May K.E., Conduit-Hulbert S.A., Villar J., Kirtley S., Kennedy S.H., Becker C.M. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update 2010, 16:651-674.
19. Rizner T.L. Noninvasive biomarkers of endometriosis: myth or reality?. Expert Rev Mol Diagn 2014, 14:365-385.
20. Pepe M.S., Etzioni R., Feng Z., Potter J.D., Thompson M.L., Thornquist M., et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 2001, 93:1054-1061.
21. Drucker E., Krapfenbauer K. Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA J 2013, 4:7.
22. Fu Q., Garnham C.P., Elliott S.T., Bovenkamp D.E., Van Eyk J.E. A robust, streamlined, and reproducible method for proteomic analysis of serum by delipidation, albumin and IgG depletion, and two-dimensional gel electrophoresis. Proteomics 2005, 5:2656-2664.
23. Ray S., Renu D., Srivastava R., Gollapalli K., Taur S., Jhaveri T., et al. Proteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers. PLoS One 2012, 7:e41751.
24. Mi H., Thomas P. PANTHER pathway: an ontology-based pathway database coupled with data analysis tools. Methods Mol Biol 2009, 563:123-140.
25. Mi H., Muruganujan A., Thomas P.D. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res 2013, 41:D377-D386.
26. Snel B., Bork P., Huynen M. Genome evolution. Gene fusion versus gene fission. Trends Genet 2000, 16:9-11.
27. Dutta M., Subramani E., Taunk K., Gajbhiye A., Seal S., Pendharkar N., et al. Mass spectrometry and bioinformatics analysis data. J Proteomics 2014, [accepted].
28. Guerriero S., Ajossa S., Mais V., Risalvato A., Lai M.P., Melis G.B. The diagnosis of endometriomas using colour Doppler energy imaging. Hum Reprod 1998, 13:1691-1695.
29. Dessole S., Farina M., Rubattu G., Cosmi E., Ambrosini G., Nardelli G.B. Sonovaginography is a new technique for assessing rectovaginal endometriosis. Fertil Steril 2003, 79:1023-1027.
30. Kinkel K., Chapron C., Balleyguier C., Fritel X., Dubuisson J.B., Moreau J.F. Magnetic resonance imaging characteristics of deep endometriosis. Hum Reprod 1999, 14:1080-1086.
31. Stratton P., Winkel C., Premkumar A., Chow C., Wilson J., Hearns-Stokes R., et al. Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis. Fertil Steril 2003, 79:1078-1085.
32. Eskenazi B., Warner M., Bonsignore L., Olive D., Samuels S., Vercellini P. Validation study of nonsurgical diagnosis of endometriosis. Fertil Steril 2001, 76:929-935.
33. Fassbender A., Vodolazkaia A., Saunders P., Lebovic D., Waelkens E., De Moor B., et al. Biomarkers of endometriosis. Fertil Steril 2013, 99:1135-1145.
34. D'Hooghe T.M., Debrock S. Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons. Hum Reprod Update 2002, 8:84-88.
35. Muyldermans M., Cornillie F.J., Koninckx P.R. CA125 and endometriosis. Hum Reprod Update 1995, 1:173-187.
36. Mol B.W., Bayram N., Lijmer J.G., Wiegerinck M.A., Bongers M.Y., van der Veen F., et al. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril 1998, 70:1101-1108.
37. Fassbender A., Waelkens E., Verbeeck N., Kyama C.M., Bokor A., Vodolazkaia A., et al. Proteomics analysis of plasma for early diagnosis of endometriosis. Obstet Gynecol 2012, 119:276-285.
38. Liu H., Lang J., Zhou Q., Shan D., Li Q. Detection of endometriosis with the use of plasma protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Fertil Steril 2007, 87:988-990.
39. Seeber B., Sammel M.D., Fan X., Gerton G.L., Shaunik A., Chittams J., et al. Proteomic analysis of serum yields six candidate proteins that are differentially regulated in a subset of women with endometriosis. Fertil Steril 2010, 93:2137-2144.
40. Wolfler M.M., Schwamborn K., Otten D., Hornung D., Liu H., Rath W. Mass spectrometry and serum pattern profiling for analyzing the individual risk for endometriosis: promising insights?. Fertil Steril 2009, 91:2331-2337.
41. Zhang H., Feng J., Chang X.H., Li Z.X., Wu X.Y., Cui H. Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifing biomarkers of endometriosis. Chin Med J (Engl) 2009, 122:373-376.
42. Baggerly K.A., Morris J.S., Coombes K.R. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 2004, 20:777-785.
43. Van Gorp T., Cadron I., Daemen A., De Moor B., Waelkens E., Vergote I. Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS. Proteome Sci 2012, 10:41.
44. Jana S.K., Dutta M., Joshi M., Srivastava S., Chakravarty B., Chaudhury K. 1H NMR based targeted metabolite profiling for understanding the complex relationship connecting oxidative stress with endometriosis. Biomed Res Int 2013, 2013:329058.
45. Singh A.K., Chattopadhyay R., Chakravarty B., Chaudhury K. Markers of oxidative stress in follicular fluid of women with endometriosis and tubal infertility undergoing IVF. Reprod Toxicol. 2013, 42:116-124.
46. Jackson L.W., Schisterman E.F., Dey-Rao R., Browne R., Armstrong D. Oxidative stress and endometriosis. Hum Reprod 2005, 20:2014-2020.
47. Gupta S., Agarwal A., Krajcir N., Alvarez J.G. Role of oxidative stress in endometriosis. Reprod Biomed Online 2006, 13:126-134.
48. Hernandez Guerrero C.A., Bujalil Montenegro L., de la Jara Diaz J., Mier Cabrera J., Bouchan Valencia P. Endometriosis and deficient intake of antioxidants molecules related to peripheral and peritoneal oxidative stress. Ginecol Obstet Mex 2006, 74:20-28.
49. Santanam N., Kavtaradze N., Murphy A., Dominguez C., Parthasarathy S. Antioxidant supplementation reduces endometriosis-related pelvic pain in humans. Transl Res 2013, 161:189-195.
50. Seeber B.E., Czech T., Buchner H., Barnhart K.T., Seger C., Daxenbichler G., et al. The vitamin E-binding protein afamin is altered significantly in the peritoneal fluid of women with endometriosis. Fertil Steril 2010, 94:2923-2926.
51. Defrere S., Lousse J.C., Gonzalez-Ramos R., Colette S., Donnez J., Van Langendonckt A. Potential involvement of iron in the pathogenesis of peritoneal endometriosis. Mol Hum Reprod 2008, 14:377-385.
52. Lousse J.C., Defrere S., Van Langendonckt A., Gras J., Gonzalez-Ramos R., Colette S., et al. Iron storage is significantly increased in peritoneal macrophages of endometriosis patients and correlates with iron overload in peritoneal fluid. Fertil Steril 2009, 91:1668-1675.
53. Mathur S.P., Lee J.H., Jiang H., Arnaud P., Rust P.F. Levels of transferrin and alpha 2-HS glycoprotein in women with and without endometriosis. Autoimmunity 1999, 29:121-127.
54. Vinatier D., Dufour P., Oosterlynck D. Immunological aspects of endometriosis. Hum Reprod Update 1996, 2:371-384.
55. Badaway S.Z., Cuenca V., Freliech H., Stefanu C. Endometrial antibodies in serum and peritoneal fluid of infertile patients with and without endometriosis. Fertil Steril 1990, 53:930-932.
56. Taylor P.V., Maloney M.D., Campbell J.M., Skerrow S.M., Nip M.M., Parmar R., et al. Autoreactivity in women with endometriosis. Br J Obstet Gynaecol 1991, 98:680-684.
57. Gilmore S.M., Aksel S., Hoff C., Peterson R.D. In vitro lymphocyte activity in women with endometriosis-an altered immune response?. Fertil Steril 1992, 58:1148-1152.
58. Hever A., Roth R.B., Hevezi P., Marin M.E., Acosta J.A., Acosta H., et al. Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator. Proc Natl Acad Sci U S A 2007, 104:12451-12456.
59. Meek S.C., Hodge D.D., Musich J.R. Autoimmunity in infertile patients with endometriosis. Am J Obstet Gynecol 1988, 158:1365-1373.
60. Gruys E., Toussaint M.J., Niewold T.A., Koopmans S.J. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B 2005, 6:1045-1056.
61. Podgaec S., Abrao M.S., Dias J.A., Rizzo L.V., de Oliveira R.M., Baracat E.C. Endometriosis: an inflammatory disease with a Th2 immune response component. Hum Reprod 2007, 22:1373-1379.
62. Bergqvist A., Bergquist C. Nordenskjold F. Lakartidningen 2000, 97:815-818.
63. Martin D.C. Pelvic inflammatory disease and endometriosis. Am J Obstet Gynecol 1995, 172:1069-1070.
64. Murphy A.A., Santanam N., Parthasarathy S. Endometriosis: a disease of oxidative stress?. Semin Reprod Endocrinol 1998, 16:263-273.
65. Lambrinoudaki I.V., Augoulea A., Christodoulakos G.E., Economou E.V., Kaparos G., Kontoravdis A., et al. Measurable serum markers of oxidative stress response in women with endometriosis. Fertil Steril 2009, 91:46-50.
66. Varma R., Rollason T., Gupta J.K., Maher E.R. Endometriosis and the neoplastic process. Reproduction 2004, 127:293-304.
67. Wolfler M.M., Meinhold-Heerlein I.M., Henkel C., Rath W., Neulen J., Maass N., et al. Reduced hemopexin levels in peritoneal fluid of patients with endometriosis. Fertil Steril 2013, 100:777-781.
68. Kobayashi H., Yamada Y., Kanayama S., Furukawa N., Noguchi T., Haruta S., et al. The role of iron in the pathogenesis of endometriosis. Gynecol Endocrinol 2009, 25:39-52.
69. Pirdel L., Pirdel M. Role of iron overload-induced macrophage apoptosis in the pathogenesis of peritoneal endometriosis. Reproduction 2014, 147:R199-R207.
70. Muller-Eberhard U., Javid J., Liem H.H., Hanstein A., Hanna M. Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. Blood 1968, 32:811-815.
71. Hwang J.H., Lee K.S., Joo J.K., Wang T., Son J.B., Park J.H., et al. Identification of biomarkers for endometriosis in plasma from patients with endometriosis using a proteomics approach. Mol Med Rep 2014, 10:725-730.
72. Delanghe J.R., Langlois M.R. Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin Chim Acta 2001, 312:13-23.
73. Pepys M.B., Stein P.E., Carrell R.W. The plasma serine protease inhibitors (serpins): structural modifications in inflammation. Acute phase proteins in the acute phase response 1989, 107-122. Springer, London.
74. Wolfler M.M., Meinhold-Heerlein I.M., Sohngen L., Rath W., Knuchel R., Neulen J., et al. Two-dimensional gel electrophoresis in peritoneal fluid samples identifies differential protein regulation in patients suffering from peritoneal or ovarian endometriosis. Fertil Steril 2011, 95:2764-2768.
75. Donadio E., Giusti L., Seccia V., Ciregia F., da Valle Y., Dallan I., et al. New insight into benign tumours of major salivary glands by proteomic approach. PLoS One 2013, 8:e71874.
76. Matalliotakis I., Neonaki M., Zolindaki A., Hassan E., Georgoulias V., Koumantakis E. Changes in immunologic variables (TNF-a, sCD8 and sCD4) during danazol treatment in patients with endometriosis. Int J Fertil Womens Med 1997, 42:211-214.
77. Darai E., Detchev R., Hugol D., Quang N.T. Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours. Hum Reprod 2003, 18:1681-1685.
78. Xavier P., Belo L., Beires J., Rebelo I., Martinez-de-Oliveira J., Lunet N., et al. Serum levels of VEGF and TNF-alpha and their association with C-reactive protein in patients with endometriosis. Arch Gynecol Obstet 2006, 273:227-231.
79. Cho S.H., Oh Y.J., Nam A., Kim H.Y., Park J.H., Kim J.H., et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. Am J Reprod Immunol 2007, 58:497-504.
80. Brenner D.A., Buck M., Feitelberg S.P., Chojkier M. Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia. J Clin Invest 1990, 85:248-255.
81. Brown D.J., Milroy R., Preston T., McMillan D.C. The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer. J Clin Pathol 2007, 60:705-708.
82. Al-Shaiba R., McMillan D.C., Angerson W.J., Leen E., McArdle C.S., Horgan P. The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases. Br J Cancer 2004, 91:205-207.
83. Parker D., Bradley C., Bogle S.M., Lay J., Masood M., Hancock A.K., et al. Serum albumin and CA125 are powerful predictors of survival in epithelial ovarian cancer. Br J Obstet Gynaecol 1994, 101:888-893.
84. Weivoda S., Andersen J.D., Skogen A., Schlievert P.M., Fontana D., Schacker T., et al. ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand. J Immunol Methods 2008, 336:22-29.
85. Norkina O., Kaur S., Ziemer D., De Lisle R.C. Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2004, 286:G1032-G1041.
86. Okano T., Kondo T., Kakisaka T., Fujii K., Yamada M., Kato H., et al. Plasma proteomics of lung cancer by a linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis. Proteomics 2006, 6:3938-3948.
87. Yu K.H., Rustgi A.K., Blair I.A. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J Proteome Res 2005, 4:1742-1751.
88. Ishioka N., Takahashi N., Putnam F.W. Amino acid sequence of human plasma alpha 1B-glycoprotein: homology to the immunoglobulin supergene family. Proc Natl Acad Sci U S A 1986, 83:2363-2367.
89. Ferrero S., Gillott D.J., Remorgida V., Anserini P., Ragni N., Grudzinskas J.G. Peritoneal fluid proteome in women with different ASRM stages of endometriosis. Gynecol Endocrinol 2008, 24:433-441.
90. Wei J., Shi Y., Zhang X., Feng Y., Luo G., Zhang J., et al. Estrogen upregulates hepatic apolipoprotein M expression via the estrogen receptor. Biochim Biophys Acta 1811, 2011:1146-1151.
91. Hu C.A., Klopfer E.I., Ray P.E. Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease. FEBS Lett 2012, 586:947-955.
92. Sheng Y., Sali A., Herzog H., Lahnstein J., Krilis S.A. Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J Immunol 1996, 157:3744-3751.
93. Jones S.E., Jomary C. Clusterin. Int J Biochem Cell Biol 2002, 34:427-431.
94. Rizzi F., Bettuzzi S. Clusterin (CLU) and prostate cancer. Adv Cancer Res 2009, 105:1-19.
95. Hassan M.K., Watari H., Han Y., Mitamura T., Hosaka M., Wang L., et al. Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting clusterin improves response to paclitaxel. J Exp Clin Cancer Res 2011, 30:113.